Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to Dicker, Adam
Item TypeName
Concept Combined Modality Therapy
Academic Article Hypofractionated stereotactic radiation therapy: an effective therapy for recurrent high-grade gliomas.
Academic Article A phase 1b trial of the combination of the antiangiogenic agent sunitinib and radiation therapy for patients with primary and metastatic central nervous system malignancies.
Academic Article Improving prognosis of glioblastoma in the 21st century: who has benefited most?
Academic Article Characterization and outcomes of optic nerve gliomas: a population-based analysis.
Academic Article The impact of brachytherapy on prostate cancer-specific mortality for definitive radiation therapy of high-grade prostate cancer: a population-based analysis.
Academic Article Tumor response to ionizing radiation combined with antiangiogenesis or vascular targeting agents: exploring mechanisms of interaction.
Academic Article Effect of the tumor vascular-damaging agent, ZD6126, on the radioresponse of U87 glioblastoma.
Academic Article A Phase II study of acute toxicity for Celebrex (celecoxib) and chemoradiation in patients with locally advanced cervical cancer: primary endpoint analysis of RTOG 0128.
Academic Article VEGF trap in combination with radiotherapy improves tumor control in u87 glioblastoma.
Academic Article Efficacy and patterns of failure for locally advanced cancer of the cervix treated with celebrex (celecoxib) and chemoradiotherapy in RTOG 0128.
Academic Article Strategic plans to promote head and neck cancer translational research within the radiation therapy oncology group: a report from the translational research program.
Academic Article COX-2 expression predicts prostate-cancer outcome: analysis of data from the RTOG 92-02 trial.
Academic Article Changes in gene expression predicting local control in cervical cancer: results from Radiation Therapy Oncology Group 0128.
Academic Article Combination of vandetanib, radiotherapy, and irinotecan in the LoVo human colorectal cancer xenograft model.
Academic Article Phase I trial using patupilone (epothilone B) and concurrent radiotherapy for central nervous system malignancies.
Search Criteria
  • Combined Modality Therapy